News for hackers. Stuff that matters.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by Loughla on Sunday September 08, 2024 @10:02PM (#41484879)
Exactly. They should be able to take whatever experimental drugs might be available.

The problem is, how do companies identify these patients or how do patients identify these companies without leaving room for massive abuse.

Maybe the treatments have to be zero cost? That feels like it would eliminate all bad actors?

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by BriggyDwiggs42 on Wednesday September 11, 2024 @02:16PM (#41513910)
That’s actually kinda a great idea imo